The most-read coverage of the latest updates in acute myeloid leukemia (AML) for 2025 focused on the evolution of targeted therapies, the promise of off-the-shelf chimeric antigen receptor (CAR) ...
The press release below was prepared by the American Association for Cancer Research. View the original here. Next-generation sequencing for minimal residual disease was highly sensitive and more ...
Cell processes are complex and are controlled through dynamic intracellular signaling. To better understand these processes, flow cytometry is used to phenotype cells by taking their dimensions and ...
Leukemia is a type of cancer that starts in immature blood cells in the bone marrow. Doctors typically use blood tests alongside other medical tools to diagnose leukemia. Most leukemias begin in cells ...
Although CLL follows a different staging format than other cancer types, diagnosing the disease properly can open the doors for more effective treatment and management strategies. Diagnosing and ...
IRVINE, Calif.--(BUSINESS WIRE)--Genomic Testing Cooperative, LCA (GTC) announced that its innovative artificial intelligence (AI) algorithms are now formally implemented in daily use to aid ...
It is rare for patients with chronic lymphocytic leukemia (CLL) to present with ocular involvement, but a mutational test could help clinicians identify patients more quickly. Testing for myeloid ...
Flow cytometry detects and measures the chemical, fluorescent, and physical characteristics of cells and particles passing in a fluid stream. This technique analyzes cells by passing them through ...
Immunophenotyping helps doctors diagnose and classify specific blood cell cancers, like leukemia and lymphoma, as well as other diseases. Immunophenotyping is a lab test doctors use to identify and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback